Targeting Enzymes for Pharmaceutical Development: Methods and Protocols (Methods in Molecular Biology, 3021)
Language: English
Published by Humana, 2026
- Hardcover
- New

Seller: Biblios, frankfurt am main, hessen, GermanyBiblios
AbeBooks seller since September 10, 2024
Condition: New
US$ 322.98
Quantity: 4 available
Add to basketItem description from seller
PRINT ON DEMAND.
Seller Inventory # 18405342641
- Title
- Targeting Enzymes for Pharmaceutical Development: Methods and Protocols (Methods in Molecular Biology, 3021)
- Publisher
- Humana
- Publication year
- 2026
- Condition
- New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 1071651897
- ISBN 13
- 9781071651896
- Edition
- 2nd Edition
This second edition volume expands on the previous edition with a discussion of the latest experimental and computational strategies used in the study, characterization, and targeting of enzymes with therapeutic potential. The chapters in the book are organized into two parts: Part One presents detailed, reproducible protocols for enzyme characterization, inhibitor screening, and biochemical analysis. Part Two is dedicated to computational and in silico methodologies, reflecting the growing impact of computational biology in drug discovery. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Cutting-edge and authoritative, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols, Second Edition is a valuable resource for academic and industrial scientists in medicinal chemistry, chemical biology, pharmaceutical biotechnology, structural biology, and computational drug discovery. This book is both a technical manual and conceptual guide for scientists engaged in enzyme-related drug discovery and development.
"Synopsis" may belong to another edition of this title.
From the Back Cover
This second edition volume expands on the previous edition with a discussion of the latest experimental and computational strategies used in the study, characterization, and targeting of enzymes with therapeutic potential. The chapters in the book are organized into two parts: Part One presents detailed, reproducible protocols for enzyme characterization, inhibitor screening, and biochemical analysis. Part Two is dedicated to computational and in silico methodologies, reflecting the growing impact of computational biology in drug discovery. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Cutting-edge and authoritative, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols, Second Edition is a valuable resource for academic and industrial scientists in medicinal chemistry, chemical biology, pharmaceutical biotechnology, structural biology, and computational drug discovery. This book is both a technical manual and conceptual guide for scientists engaged in enzyme-related drug discovery and development.
"About the title" may belong to another edition of this title.
Biblios
frankfurt am main, hessen, Germany
AbeBooks seller since September 10, 2024
Shipping rates from Germany to U.S.A.
| Item | 25 to 45 business days | 8 to 14 business days |
|---|---|---|
| First item | US$ 11.13 | US$ 20.91 |
Payment methods
Store description
We carry a wide selection of books from South Asia, United States, UK.
Specialty
new books imported from india, uk, usaSeller's business information
Readingos GmbH
Kaiserstraße 47
Frankfurt am Main, Germany 60329
Shipping terms
To ensure faster delivery, books may be shipped from any of the following locations Germany, the United Kingdom (UK), the United States (US), based on the buyer's address and product availability.